Cargando…
Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion
Severe acute respiratory syndrome coronavirus (SARS-CoV) poses a considerable threat to human health. Activation of the viral spike (S)-protein by host cell proteases is essential for viral infectivity. However, the cleavage sites in SARS-S and the protease(s) activating SARS-S are incompletely defi...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086175/ https://www.ncbi.nlm.nih.gov/pubmed/21435673 http://dx.doi.org/10.1016/j.virol.2011.02.020 |
_version_ | 1782202679888445440 |
---|---|
author | Simmons, Graham Bertram, Stephanie Glowacka, Ilona Steffen, Imke Chaipan, Chawaree Agudelo, Juliet Lu, Kai Rennekamp, Andrew J. Hofmann, Heike Bates, Paul Pöhlmann, Stefan |
author_facet | Simmons, Graham Bertram, Stephanie Glowacka, Ilona Steffen, Imke Chaipan, Chawaree Agudelo, Juliet Lu, Kai Rennekamp, Andrew J. Hofmann, Heike Bates, Paul Pöhlmann, Stefan |
author_sort | Simmons, Graham |
collection | PubMed |
description | Severe acute respiratory syndrome coronavirus (SARS-CoV) poses a considerable threat to human health. Activation of the viral spike (S)-protein by host cell proteases is essential for viral infectivity. However, the cleavage sites in SARS-S and the protease(s) activating SARS-S are incompletely defined. We found that R667 was dispensable for SARS-S-driven virus–cell fusion and for SARS-S-activation by trypsin and cathepsin L in a virus–virus fusion assay. Mutation T760R, which optimizes the minimal furin consensus motif 758-RXXR-762, and furin overexpression augmented SARS-S activity, but did not result in detectable SARS-S cleavage. Finally, SARS-S-driven cell–cell fusion was independent of cathepsin L, a protease essential for virus–cell fusion. Instead, a so far unknown leupeptin-sensitive host cell protease activated cellular SARS-S for fusion with target cells expressing high levels of ACE2. Thus, different host cell proteases activate SARS-S for virus–cell and cell–cell fusion and SARS-S cleavage at R667 and 758-RXXR-762 can be dispensable for SARS-S activation. |
format | Text |
id | pubmed-3086175 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-30861752012-05-10 Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion Simmons, Graham Bertram, Stephanie Glowacka, Ilona Steffen, Imke Chaipan, Chawaree Agudelo, Juliet Lu, Kai Rennekamp, Andrew J. Hofmann, Heike Bates, Paul Pöhlmann, Stefan Virology Article Severe acute respiratory syndrome coronavirus (SARS-CoV) poses a considerable threat to human health. Activation of the viral spike (S)-protein by host cell proteases is essential for viral infectivity. However, the cleavage sites in SARS-S and the protease(s) activating SARS-S are incompletely defined. We found that R667 was dispensable for SARS-S-driven virus–cell fusion and for SARS-S-activation by trypsin and cathepsin L in a virus–virus fusion assay. Mutation T760R, which optimizes the minimal furin consensus motif 758-RXXR-762, and furin overexpression augmented SARS-S activity, but did not result in detectable SARS-S cleavage. Finally, SARS-S-driven cell–cell fusion was independent of cathepsin L, a protease essential for virus–cell fusion. Instead, a so far unknown leupeptin-sensitive host cell protease activated cellular SARS-S for fusion with target cells expressing high levels of ACE2. Thus, different host cell proteases activate SARS-S for virus–cell and cell–cell fusion and SARS-S cleavage at R667 and 758-RXXR-762 can be dispensable for SARS-S activation. Elsevier Inc. 2011-05-10 2011-03-23 /pmc/articles/PMC3086175/ /pubmed/21435673 http://dx.doi.org/10.1016/j.virol.2011.02.020 Text en Copyright © 2011 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Simmons, Graham Bertram, Stephanie Glowacka, Ilona Steffen, Imke Chaipan, Chawaree Agudelo, Juliet Lu, Kai Rennekamp, Andrew J. Hofmann, Heike Bates, Paul Pöhlmann, Stefan Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion |
title | Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion |
title_full | Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion |
title_fullStr | Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion |
title_full_unstemmed | Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion |
title_short | Different host cell proteases activate the SARS-coronavirus spike-protein for cell–cell and virus–cell fusion |
title_sort | different host cell proteases activate the sars-coronavirus spike-protein for cell–cell and virus–cell fusion |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086175/ https://www.ncbi.nlm.nih.gov/pubmed/21435673 http://dx.doi.org/10.1016/j.virol.2011.02.020 |
work_keys_str_mv | AT simmonsgraham differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT bertramstephanie differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT glowackailona differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT steffenimke differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT chaipanchawaree differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT agudelojuliet differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT lukai differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT rennekampandrewj differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT hofmannheike differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT batespaul differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion AT pohlmannstefan differenthostcellproteasesactivatethesarscoronavirusspikeproteinforcellcellandviruscellfusion |